Ketoconazole is an imidazole antifungal medication that is commonly formulated as a cream, shampoo or oral agent. Clinically it is employed to manage dermatophyte infections and cutaneous mycoses. The drug exerts its therapeutic effect by disrupting fungal sterol synthesis leading to loss of membrane integrity. This occurs through inhibition of the cytochrome p450 14 alpha demethylase enzyme required for conversion of lanosterol to ergosterol. The resulting depletion of ergosterol compromises fungal cell membrane stability and increases permeability to essential cellular components. Systemic absorption enables the agent to act against organisms located beneath the stratum corneum and in adjacent tissues. Its hydrophobic nature allows partitioning into the stratum corneum where it reversibly partitions and maintains sufficient concentrations to inhibit fungal growth. The overall pharmacological outcome is selective fungal eradication while sparing host sterol pathways.

Ketoconazole is an imidazole-derived antifungal medication that works by inhibiting the fungal cytochrome p450 enzyme involved in ergosterol synthesis. By blocking ergosterol production, the drug disrupts the integrity of the fungal cell membrane, leading to reduced growth and eventual cell death. Ergosterol is essential for maintaining membrane fluidity, so its depletion compromises membrane function and increases permeability. The pharmacologic effect is achieved through selective binding to the active site of the enzyme lanosterol 14a-demethylase, which prevents conversion of lanosterol to ergosterol. This interaction specifically targets fungal cells, limiting toxicity to human tissue while effectively reducing fungal colonization. Ketoconazole is also used as a systemic antifungal when oral administration provides adequate bioavailability. The overall therapeutic role of the drug is to treat a range of systemic and superficial fungal infections by interfering with sterol biosynthesis.

Headache, dizziness, and mild nausea are among the most frequently observed side effects, often resolving without intervention. Fatigue and temporary sleep disturbances may occur, especially during the adjustment period. Flushing of the skin and brief warmth sensations are common but generally harmless. Some individuals report mild gastrointestinal discomfort such as stomach upset or diarrhea. Changes in appetite or slight weight fluctuation can be noted in a minority of cases. Muscle aches and joint stiffness are occasionally reported, typically mild and short-lived. Cardiac awareness, such as an increased awareness of heartbeat, may be experienced briefly. These reactions are generally self-limited and do not require treatment beyond monitoring.

Headache is frequently reported after treatment sessions. Mild nausea may occur during or immediately after procedures. Fatigue is often noted in the hours following appointments. Temporary skin redness can appear at contact sites. Some individuals experience brief dizziness that resolves quickly. Sleep disturbances such as occasional restlessness have been observed.